NO20033125L - Anvendelse av antigestagener til inhibering av fremskyndet endometriummodning under infertilitetsbehandling - Google Patents

Anvendelse av antigestagener til inhibering av fremskyndet endometriummodning under infertilitetsbehandling

Info

Publication number
NO20033125L
NO20033125L NO20033125A NO20033125A NO20033125L NO 20033125 L NO20033125 L NO 20033125L NO 20033125 A NO20033125 A NO 20033125A NO 20033125 A NO20033125 A NO 20033125A NO 20033125 L NO20033125 L NO 20033125L
Authority
NO
Norway
Prior art keywords
antigestagens
maturation during
endometrial maturation
infertility therapy
during infertility
Prior art date
Application number
NO20033125A
Other languages
English (en)
Norwegian (no)
Other versions
NO20033125D0 (no
Inventor
Christa Hegele-Hartung
Holger Hess-Stumpp
Henning M Beier
Claudia Krusche
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/801,925 external-priority patent/US20020143000A1/en
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20033125D0 publication Critical patent/NO20033125D0/no
Publication of NO20033125L publication Critical patent/NO20033125L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO20033125A 2001-01-09 2003-07-08 Anvendelse av antigestagener til inhibering av fremskyndet endometriummodning under infertilitetsbehandling NO20033125L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75628601A 2001-01-09 2001-01-09
US09/801,925 US20020143000A1 (en) 2001-01-09 2001-03-09 Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
PCT/IB2002/001764 WO2002067910A2 (en) 2001-01-09 2002-01-09 The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment

Publications (2)

Publication Number Publication Date
NO20033125D0 NO20033125D0 (no) 2003-07-08
NO20033125L true NO20033125L (no) 2003-09-09

Family

ID=27116200

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033125A NO20033125L (no) 2001-01-09 2003-07-08 Anvendelse av antigestagener til inhibering av fremskyndet endometriummodning under infertilitetsbehandling

Country Status (24)

Country Link
US (1) US20040152684A1 (enExample)
EP (1) EP1365765B1 (enExample)
JP (1) JP2004520411A (enExample)
CN (1) CN1244329C (enExample)
AR (1) AR032390A1 (enExample)
AT (1) ATE367817T1 (enExample)
AU (1) AU2002253488B2 (enExample)
BG (1) BG107977A (enExample)
BR (1) BR0206367A (enExample)
CA (1) CA2433776A1 (enExample)
CZ (1) CZ20031864A3 (enExample)
DE (1) DE60221359T2 (enExample)
DK (1) DK1365765T3 (enExample)
EE (1) EE200300321A (enExample)
ES (1) ES2290284T3 (enExample)
HR (1) HRP20030628A2 (enExample)
HU (1) HUP0302632A2 (enExample)
IL (1) IL156729A0 (enExample)
MX (1) MXPA03006156A (enExample)
NO (1) NO20033125L (enExample)
NZ (1) NZ526908A (enExample)
PL (1) PL361689A1 (enExample)
SK (1) SK8612003A3 (enExample)
WO (1) WO2002067910A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009034362A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) * 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
US20130029953A1 (en) * 2011-07-28 2013-01-31 Klaus Nickisch Progesterone antagonists
EP3501533B1 (en) * 2014-12-22 2025-07-09 Ferring B.V. Obe001 for use in the treatment in implantation and pregnancy in women undergoing assisted reproductive technologies
EP3214092A1 (en) 2016-03-04 2017-09-06 Bayer Pharma Aktiengesellschaft Prodrugs of the selective progesterone receptor modulator (sprm) (11.beta.,17.beta.)-17-hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3533175A1 (de) * 1985-09-13 1987-03-19 Schering Ag Antigestagene zur verschiebung der endometrialen reifung
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
DE19860719A1 (de) * 1998-12-23 2000-06-29 Schering Ag Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen

Also Published As

Publication number Publication date
US20040152684A1 (en) 2004-08-05
ES2290284T3 (es) 2008-02-16
BR0206367A (pt) 2003-12-23
BG107977A (bg) 2004-08-31
IL156729A0 (en) 2004-02-08
HK1065953A1 (en) 2005-03-11
WO2002067910A2 (en) 2002-09-06
ATE367817T1 (de) 2007-08-15
CZ20031864A3 (en) 2004-03-17
DK1365765T3 (da) 2007-10-29
DE60221359D1 (de) 2007-09-06
WO2002067910A3 (en) 2003-02-06
NZ526908A (en) 2005-07-29
CA2433776A1 (en) 2002-09-06
EP1365765A2 (en) 2003-12-03
EP1365765B1 (en) 2007-07-25
HUP0302632A2 (hu) 2003-11-28
DE60221359T2 (de) 2008-04-17
CN1496263A (zh) 2004-05-12
NO20033125D0 (no) 2003-07-08
HRP20030628A2 (en) 2005-06-30
SK8612003A3 (en) 2004-03-02
PL361689A1 (en) 2004-10-04
AU2002253488B2 (en) 2007-02-15
EE200300321A (et) 2003-10-15
AR032390A1 (es) 2003-11-05
JP2004520411A (ja) 2004-07-08
MXPA03006156A (es) 2003-09-16
CN1244329C (zh) 2006-03-08

Similar Documents

Publication Publication Date Title
IL161733A0 (en) Methods and compositions for therapeutic use of rna interference
IL208892A0 (en) Use of hmg fragment as anti-inflammatory agents
NO20030030D0 (no) Farmasöytiske blandinger av östrogene midler
HUP0201310A3 (en) Therapeutic use of selective pde10 inhibitors
HUP0300497A3 (en) Inhibitors of human phosphatidyl-inositol 3-kinase delta
NO20015112L (no) Anvendelse av glykosylceramidsynteseinhibitorer ved terapi
EP1446012A4 (en) Bacteriolytic combination therapy for the treatment of tumors
GB0030918D0 (en) Activation of voice-controlled apparatus
EP1494678A4 (en) hormone therapy PROCEDURE
EE200200632A (et) Glükokortikoidravimeid sisaldavad preparaadid bronhopulmonaalsete haiguste raviks
NO20033125L (no) Anvendelse av antigestagener til inhibering av fremskyndet endometriummodning under infertilitetsbehandling
EP1357919A4 (en) GLUCANE ENHANCING THERAPY
ZA200306122B (en) The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment.
NO20023354L (no) Anvendelse av FSH til å behandle infertilitet
GB0029573D0 (en) Activation of voice-controlled apparatus
NO20034246D0 (no) Enkel dose av aromataseinhibitor for behandling av ufruktbarhet
IL162509A0 (en) Use of deoxypeganine for treating clinical depression
AU151113S (en) Set of bathroom accessories
GB0123777D0 (en) Substituted chalcones as therapeutic agents
ITAN20020045A0 (it) Attrezzatura per pratica della terapia delle pietre calde
TW479522U (en) Structure of basin for soaking foot
ITMI20011705A0 (it) Antiinfiammatori non asteroidei per il trattamento per via rettale dioligastenospermia
AU149290S (en) Set of bathroom accessories
AU151131S (en) Set of bathroom accessories
NO990987D0 (no) Fremstilling av homogene gassblandinger

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application